When can maximal efficacy occur with repeat botulinum toxin injection in upper limb spastic paresis?
abobotulinumtoxinA
maximal effect
non‐linear random coefficient
repeat injection
upper limb spastic paresis
Journal
Brain communications
ISSN: 2632-1297
Titre abrégé: Brain Commun
Pays: England
ID NLM: 101755125
Informations de publication
Date de publication:
2021
2021
Historique:
received:
18
02
2020
revised:
05
08
2020
accepted:
28
08
2020
entrez:
5
2
2021
pubmed:
6
2
2021
medline:
6
2
2021
Statut:
epublish
Résumé
Repeated injection cycles with abobotulinumtoxinA, a botulinum toxin type A, are recommended in current clinical guidelines as a treatment option for adults with upper limb spastic paresis. However, the magnitude of the maximal therapeutic effect of repeated abobotulinumtoxinA treatment across different efficacy parameters and the number of injection cycles required to reach maximal effect remain to be elucidated. Here, we present a
Identifiants
pubmed: 33543139
doi: 10.1093/braincomms/fcaa201
pii: fcaa201
pmc: PMC7850141
doi:
Types de publication
Journal Article
Langues
eng
Pagination
fcaa201Informations de copyright
© The Author(s) (2020). Published by Oxford University Press on behalf of the Guarantors of Brain.
Références
Curr Opin Neurol. 2001 Dec;14(6):771-6
pubmed: 11723387
Clin Rehabil. 2020 Jun;34(6):803-811
pubmed: 32336148
Neurology. 2016 May 10;86(19):1818-26
pubmed: 27164716
Lancet Neurol. 2015 Oct;14(10):992-1001
pubmed: 26318836
Am J Phys Med Rehabil. 2015 Mar;94(3):229-38
pubmed: 25299523
J Neurol Neurosurg Psychiatry. 2004 Nov;75(11):1547-51
pubmed: 15489384
Muscle Nerve. 2018 Feb;57(2):245-254
pubmed: 28590525
Int J Clin Pract. 2008 Aug;62(8):1147-58
pubmed: 18564199
Pharm Stat. 2018 Sep;17(5):515-526
pubmed: 29781237
Neurology. 2004 Nov 23;63(10):1971-3
pubmed: 15557529
Eur J Phys Rehabil Med. 2010 Sep;46(3):411-21
pubmed: 20927007
Int J Neurosci. 2018 Nov;128(11):1030-1039
pubmed: 29619890
Arch Phys Med Rehabil. 2002 Oct;83(10):1349-54
pubmed: 12370866